Fused tricyclic compounds, methods and compositions for inhibiting parp activity
AssigneeGuilford Pharmaceuticals Inc.
InventorsJia-He Li, Jie Zhang
Life of this patent
Estimating the term…
Loading patent…
AssigneeGuilford Pharmaceuticals Inc.
InventorsJia-He Li, Jie Zhang
Estimating the term…
A compound of formula I: 1 or a pharmaceutically acceptable salt, hydrate, ester, solvate, prodrug, metabolite, stereoisomer, or mixtures thereof, wherein the compound of formula I is present in an amount that is effective for treating diabetes; and wherein: Y represents the atoms necessary to form a fused 5- to 6-membered, aromatic or non-aromatic, carbocyclic or heterocyclic ring, wherein Y and any heteroatom(s) therein is unsubstituted or independently substituted with at least one non-interfering hydroxy, amino, nitro, dimethylamino, alkylamino, alkyl, alkenyl, cycloalkyl, cycloalkenyl, aralkyl or aryl substituent; R1 and R3 are independently hydrogen, alkyl, halo, alkenyl, cycloalkyl, cycloalkenyl, aralkyl, aryl, double bonded oxygen, —COOR5, or a moiety selected from the group consisting of: 2 wherein R7 is alkyl, alkenyl, cycloalkyl, cycloalkenyl, aralkyl or aryl; R2, when present, is hydrogen, alkyl, alkenyl, amino, cycloalkyl, cycloalkenyl, aralkyl or aryl; R4, R5 and R6 are independently hydrogen, hydroxy, amino, dimethylamino, alkylamino, nitro, alkyl, alkenyl, cycloalkyl, cycloalkenyl, aralkyl or aryl; wherein R2, R4, R5 and R6 are unsubstituted or independently substituted with a moiety selected from the group consisting of alkyl, alkenyl, alkoxy, phenoxy, benzyloxy, cycloalkyl, cycloalkenyl, hydroxy, carboxy, carbonyl, amino, dimethylamino, alkylamino, amido, cyano, isocyano, nitro, nitroso, nitrilo, isonitrilo, imino, azo, diazo, sulfonyl, sulfoxy, thio, thiocarbonyl, alkylthio, sulfhydryl, halo, haloalkyl, trifluoromethyl and aryl.
A compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula I:
A method of inhibiting PARP activity comprising administering a compound of formula I:
A method of effecting a neuronal activity not mediated by NMDA toxicity in an animal comprising administering to said animal an effective amount of a compound of formula I:
A method of treating arthritis in an animal comprising administering to said animal an effective amount of a compound of formula I:
A method of treating diabetes in an animal comprising administering to said animal an effective amount of a compound of formula I:
A method of treating an inflammatory bowel disorder in an animal comprising administering to said animal an effective amount of a compound of formula I:
A method of treating a cardiovascular in an animal comprising administering to said animal an effective amount of a compound of formula I:
A method of treating septic shock in an animal comprising administering to said animal an effective amount of a compound of formula I:
A method of treating cancer in an animal comprising administering to said animal an effective amount of a compound of formula I:
A method radiosensitizing tumor cells comprising administering an effective amount of a compound of formula I:
A method for increasing or extending the lifespan or proliferative capacity of cells or altering the gene expression of senescent cells comprising administering an effective amount of a compound of formula I:
A process of making the compound of formula I:
The compounds, compositions, methods and processes described herein.
Dependencies are inferred from the claim text.